US › Healthcare

Sanara Medtech Inc (SMTI)

US · Healthcare · Medical Instruments & Supplies

$34.98-0.34%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$28.1M

Revenue YoY

+8.9%

Net profit

$-452,864

EPS

$0.05

EPS estimate

$0.02

Net margin

-1.6%

EPS came in at 0.05 against a street estimate of 0.02 — a beat of 150.0%.

Key statistics

Market cap

$321.4M

Forward P/E

217.4

P/B

40.40

Book value

$0.77

EPS (TTM)

$-0.04

52-week high

$35.53

52-week low

$16.05

50-day MA

$31.15

200-day MA

$23.62

Beta

1.16

Analyst view

Analysts rate Sanara Medtech Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $35.00.

Shareholding

Insiders

47.98%

Institutions

19.92%

Largest institutional holders

Fund	Stake
BlackRock Inc	2.56%
Vanguard Capital Management, LLC	1.69%
Royal Bank of Canada	1.47%
Stonebridge Wealth Management, LLC	1.45%
Geode Capital Management, LLC	0.96%
Marshall Wace Asset Management Ltd	0.85%
Squarepoint Ops LLC	0.82%
Renaissance Technologies Corp	0.72%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sanara Medtech Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.